1-4 of 4
Kazuko Sakai
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Afatinib against Esophageal or Head-and-Neck Squamous Cell Carcinoma: Significance of Activating Oncogenic HER4 Mutations in HNSCC

Yu Nakamura, Yosuke Togashi, Hirokazu Nakahara, Shuta Tomida, Eri Banno, Masato Terashima, Hidetoshi Hayashi, Marco A. de Velasco, Kazuko Sakai, Yoshihiko Fujita, Takatsugu Okegawa, Kikuo Nutahara, Suguru Hamada, Kazuto Nishio
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (8): 1988–1997.
https://doi.org/10.1158/1535-7163.MCT-15-0737
Published: 03 August 2016
View article titled, Afatinib against Esophageal or Head-and-Neck Squamous Cell Carcinoma: Significance of Activating Oncogenic <em>HER4</em> Mutations in HNSCC
Open the PDF for Afatinib against Esophageal or Head-and-Neck Squamous Cell Carcinoma: Significance of Activating Oncogenic <em>HER4</em> Mutations in HNSCC in another window
Includes: Supplementary data
Journal Articles

MEK Inhibitor for Gastric Cancer with MEK1 Gene Mutations

Shunsuke Sogabe, Yosuke Togashi, Hiroaki Kato, Akihiro Kogita, Takuro Mizukami, Yoichi Sakamoto, Eri Banno, Masato Terashima, Hidetoshi Hayashi, Marco A. de Velasco, Kazuko Sakai, Yoshihiko Fujita, Shuta Tomida, Takushi Yasuda, Yoshifumi Takeyama, Kiyotaka Okuno, Kazuto Nishio
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2014) 13 (12): 3098–3106.
https://doi.org/10.1158/1535-7163.MCT-14-0429
Published: 04 December 2014
View article titled, MEK Inhibitor for Gastric Cancer with <em>MEK1</em> Gene Mutations
Open the PDF for MEK Inhibitor for Gastric Cancer with <em>MEK1</em> Gene Mutations in another window
Includes: Supplementary data
Journal Articles

Antitumor Action of the MET Tyrosine Kinase Inhibitor Crizotinib (PF-02341066) in Gastric Cancer Positive for MET Amplification

Wataru Okamoto, Isamu Okamoto, Tokuzo Arao, Kiyoko Kuwata, Erina Hatashita, Haruka Yamaguchi, Kazuko Sakai, Kazuyoshi Yanagihara, Kazuto Nishio, Kazuhiko Nakagawa
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (7): 1557–1564.
https://doi.org/10.1158/1535-7163.MCT-11-0934
Published: 05 July 2012
View article titled, Antitumor Action of the MET Tyrosine Kinase Inhibitor Crizotinib (PF-02341066) in Gastric Cancer Positive for <em>MET</em> Amplification
Open the PDF for Antitumor Action of the MET Tyrosine Kinase Inhibitor Crizotinib (PF-02341066) in Gastric Cancer Positive for <em>MET</em> Amplification in another window
Includes: Supplementary data
Journal Articles

Sorafenib Inhibits the Hepatocyte Growth Factor–Mediated Epithelial Mesenchymal Transition in Hepatocellular Carcinoma

Tomoyuki Nagai, Tokuzo Arao, Kazuyuki Furuta, Kazuko Sakai, Kanae Kudo, Hiroyasu Kaneda, Daisuke Tamura, Keiichi Aomatsu, Hideharu Kimura, Yoshihiko Fujita, Kazuko Matsumoto, Nagahiro Saijo, Masatoshi Kudo, Kazuto Nishio
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (1): 169–177.
https://doi.org/10.1158/1535-7163.MCT-10-0544
Published: 10 January 2011
View article titled, Sorafenib Inhibits the Hepatocyte Growth Factor–Mediated Epithelial Mesenchymal Transition in Hepatocellular Carcinoma
Open the PDF for Sorafenib Inhibits the Hepatocyte Growth Factor–Mediated Epithelial Mesenchymal Transition in Hepatocellular Carcinoma in another window
Includes: Supplementary data